Filing Flows › Sanofi (SNY) › Q1 2026 › vs Q1 2025
Sanofi (SNY) Q1 2026 vs Q1 2025 (year over year)
Sanofi's revenue rose $614M (+6%) from $9.9B in Q1 2025 to $10.5B in Q1 2026. Gross margin 77.1% against 78.0% (-0.9 pts).
Sanofi, Q1 2026: revenue $10.5B (+6% year over year), operating margin 20.2%, net earnings $1.6B, operating cash flow $1.7B. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Gross margin | 77.1% | 78.0% | -0.9 pts |
| Operating margin | 20.2% | 23.1% | -2.9 pts |
| Net margin | 15.4% | 18.9% | -3.6 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $10.5B | $9.9B | $614M | +6% |
| Gross profit | $8.1B | $7.7B | $389M | +5% |
| Cost of revenue | $2.4B | $2.2B | $225M | +10% |
| Operating profit | $2.1B | $2.3B | −$164M | -7% |
| Operating expenses | $6.0B | $5.4B | $553M | +10% |
| Pre-tax earnings | $1.2B | $1.4B | −$212M | -15% |
| Other expense, net | $921M | $873M | $48.0M | +5% |
| Research & development | $1.7B | $1.8B | −$61.0M | -3% |
| Other operating costs | $4.2B | $3.6B | $614M | +17% |
| Income tax benefit | $420M | $481M | −$61.0M | -13% |
| Net earnings | $1.6B | $1.9B | −$258M | -14% |
| Minority interests | $6.0M | $21.0M | −$15.0M | -71% |
| Working capital & other | $69.0M | $221M | −$152M | -69% |
| Operating cash flow | $1.7B | $2.1B | −$410M | -20% |
Questions
How much did Sanofi's revenue grow year over year in Q1 2026?
Sanofi's revenue rose $614M (+6%) from $9.9B in Q1 2025 to $10.5B in Q1 2026. Gross margin 77.1% against 78.0% (-0.9 pts).